FDA Adverse Event Injury Summary report: N

OT ULTRA2 METER

MDR report key: 3971918 · Received July 31, 2014

Report

Report Number
2939301-2014-19271
Event Type
Injury
Date Received
July 31, 2014
Date of Event
July 23, 2014
Report Date
July 25, 2014
Manufacturer
LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL
Product Code
NBW
PMA / PMN Number
K053529
Adverse Event
Yes
Report Source
Manufacturer report
Reporter Location
PA, US
Reporter Occupation
PATIENT

Narratives

Additional Manufacturer Narrative · 1

LIFESCAN (LFS) HAS REQUESTED RETURN OF THE SUBJECT PRODUCT(S) FOR EVALUATION. IF THE PRODUCT(S) ARE RETURNED, LFS WILL EVALUATE IT/THEM AND INFORM FDA OF PRODUCT(S) THAT DO NOT PASS INSPECTION IN A SUPPLEMENTAL REPORT.

Description of Event or Problem · 1

ON (B)(6) 2014, THE LAY USER/REPORTER CONTACTED LIFESCAN TO REPORT THE ONETOUCH ULTRA2 METER WAS GIVING THE ¿APPLY SAMPLE¿ ICON DURING TESTING. THE SR. MEDICAL SURVEILLANCE SPECIALIST CLASSIFIED THE COMPLAINT BASED ON THE INFORMATION PROVIDED TO CUSTOMER SERVICE. ON (B)(6) 2014 THE PATIENT OBTAINED THE ¿APPLY SAMPLE¿ ICON ON THE REPORTED METER DURING TESTING; HE DID NOT OBTAIN A BLOOD GLUCOSE READING. THE PATIENT TOOK NO ACTIONS DUE TO THIS METER ISSUE. THE PATIENT MANAGES HIS DIABETES WITH INSULIN TAKEN ON A SLIDING SCALE. ONE DAY AFTERWARDS, THE PATIENT EXPERIENCED THE SYMPTOMS OF SHAKING AND LIGHTHEADEDNESS; HE DID NOT SEEK ANY MEDICAL ATTENTION OR TREATMENT. TROUBLESHOOTING REVEALED THE PATIENT¿S TEST STRIPS WERE CORRECT AND CORRECTLY DREW IN THE BLOOD SAMPLE AND THE PATIENT¿S TESTING TECHNIQUE WAS CORRECT. THE ISSUE WAS NOT RESOLVED. THE METER, TEST STRIPS AND CONTROL SOLUTION WERE REPLACED. THE PATIENT ALLEGEDLY SUFFERED SYMPTOMS SUGGESTING SEVERE HYPOGLYCEMIA AFTER HE WAS UNABLE TO TEST HIS BLOOD GLUCOSE LEVEL DUE TO THE METER ISSUE. THEREFORE THIS COMPLAINT IS BEING REPORTED.

Devices

Seq Brand Generic Product Code Manufacturer Model Lot UDI-DI
446503 OT ULTRA2 METER GLUCOSE MONITORING SYS/KIT NBW LIFESCAN EUROPE, A DIVISION OF CILAG GMBH INTL 3623084

Patients

Seq Age Sex Outcome Treatment
1 40 YR Life Threatening